
Sakata Seed Corporation
SAKATA
Sakata Seed Corporation is a Japanese seed house founded in Yokohama in 1913, listed on the Tokyo Stock Exchange Prime market under code 1377 and selling its genetics worldwide under the single brand SAKATA. It is not a Fortune Global 500 member: FY2026 revenue of JPY 104.2 billion, roughly US$680 million, is below the threshold used to draw up the 2025 list. Its 81 score rests instead on a share of one vegetable crop that no other company on this table comes close to holding.
The company began as a Yokohama seed merchant and spent the twentieth century becoming a breeder that develops, multiplies and finishes its own varieties rather than trading other people's. Broccoli became the franchise. Sakata's share of the world broccoli seed market is put at more than 60 percent in one of the two research documents behind this profile and 65 percent in the other; either number makes it the reference manufacturer for the crop. Ornamentals are the second leg, led by the SunPatiens impatiens series and lisianthus varieties sold to professional flower growers. FY2026 sales reached JPY 104.2 billion and net profit rose 25 percent to JPY 12.1 billion, a year in which profit outgrew turnover.
Category purity is high and deliberate. The portfolio is seed, not agrochemicals: proprietary hybrids in broccoli, cabbage, lettuce, watermelon and tomato on the vegetable side, and in impatiens, lisianthus and other cut-flower and bedding crops on the ornamental side. There is no crop protection or fertiliser line sitting alongside, so margin depends on genetics, on seed quality and on the production discipline behind it.
Physical assets follow the seed. Breeding farms, tissue-culture laboratories and seed processing plants operate across 22 countries, with high-specification cleaning plants and trial grounds in Japan, in California, in France, in Brazil and in Suzhou in China. Gravity separation, sizing and coating lines of that kind are what allow a breeder to commit to germination percentages and lot-to-lot uniformity instead of buying cleaned seed from a third party. Tissue culture adds a second production route for crops where in-vitro propagation beats field multiplication.
Sales are business-to-business. Customers are professional growers, distributors and, in flowers, plug and young-plant producers in more than 130 countries, and gross margin has been held above 45 percent on proprietary varieties rather than on volume. Two recent decisions point the same way: the Antalya Research Farm opened in Turkey in 2025, and in 2026 the Spanish subsidiary moved its headquarters to Almeria, both aimed at the protected-culture vegetable growers of the Mediterranean basin.
The first risk is currency translation. A Japanese company earning in dollars and euros against a yen cost base absorbs the full effect of yen volatility, and rising labour costs at overseas farms, processing sites and research stations squeeze the margin on cross-border operations in the short run. The second is delivery on PASSION2035, the ten-year plan adopted on 13 July 2026 with a target of JPY 200 billion in annual sales by FY2036, close to double the current figure, which depends on growth rates the vegetable and flower franchises have not recently produced.
Read More ▼Show Less ▲
Sakata Seed Corporation is a Japanese seed house founded in Yokohama in 1913, listed on the Tokyo Stock Exchange Prime market under code 1377 and selling its genetics worldwide under the single brand SAKATA. It is not a Fortune Global 500 member: FY2026 revenue of JPY 104.2 billion, roughly US$680 million, is below the threshold used to draw up the 2025 list. Its 81 score rests instead on a share of one vegetable crop that no other company on this table comes close to holding.
The company began as a Yokohama seed merchant and spent the twentieth century becoming a breeder that develops, multiplies and finishes its own varieties rather than trading other people's. Broccoli became the franchise. Sakata's share of the world broccoli seed market is put at more than 60 percent in one of the two research documents behind this profile and 65 percent in the other; either number makes it the reference manufacturer for the crop. Ornamentals are the second leg, led by the SunPatiens impatiens series and lisianthus varieties sold to professional flower growers. FY2026 sales reached JPY 104.2 billion and net profit rose 25 percent to JPY 12.1 billion, a year in which profit outgrew turnover.
Category purity is high and deliberate. The portfolio is seed, not agrochemicals: proprietary hybrids in broccoli, cabbage, lettuce, watermelon and tomato on the vegetable side, and in impatiens, lisianthus and other cut-flower and bedding crops on the ornamental side. There is no crop protection or fertiliser line sitting alongside, so margin depends on genetics, on seed quality and on the production discipline behind it.
Physical assets follow the seed. Breeding farms, tissue-culture laboratories and seed processing plants operate across 22 countries, with high-specification cleaning plants and trial grounds in Japan, in California, in France, in Brazil and in Suzhou in China. Gravity separation, sizing and coating lines of that kind are what allow a breeder to commit to germination percentages and lot-to-lot uniformity instead of buying cleaned seed from a third party. Tissue culture adds a second production route for crops where in-vitro propagation beats field multiplication.
Sales are business-to-business. Customers are professional growers, distributors and, in flowers, plug and young-plant producers in more than 130 countries, and gross margin has been held above 45 percent on proprietary varieties rather than on volume. Two recent decisions point the same way: the Antalya Research Farm opened in Turkey in 2025, and in 2026 the Spanish subsidiary moved its headquarters to Almeria, both aimed at the protected-culture vegetable growers of the Mediterranean basin.
The first risk is currency translation. A Japanese company earning in dollars and euros against a yen cost base absorbs the full effect of yen volatility, and rising labour costs at overseas farms, processing sites and research stations squeeze the margin on cross-border operations in the short run. The second is delivery on PASSION2035, the ten-year plan adopted on 13 July 2026 with a target of JPY 200 billion in annual sales by FY2036, close to double the current figure, which depends on growth rates the vegetable and flower franchises have not recently produced.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Yokohama, Kanagawa, Japan
Founded
1913
Employees
~2,800
Revenue
JPY 104.2 billion (FY2026) - about US$680 million
Factories
Breeding farms, tissue-culture labs and seed processing plants in 22 countries
Listing
Tokyo Stock Exchange Prime (1377)
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , Sakata IR filings · PASSION2035 plan · Sakata FY2026 results · Sakata Seed valuation · Sakata IR home · Sakata share data
